2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New?-Reference-Cited by-同舟云学术

2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What’s New?

Published:2023 Issue:1 Volume:24 Page:6
ISSN:1229-6929
Container-title:Korean Journal of Radiology
language:en
Short-container-title:Korean J Radiol

Author:

Lee In Joon¹^ORCID,Chun Ho Jong²^ORCID,Chung Jin Wook³^ORCID

Affiliation:

1. Department of Radiology, National Cancer Center, Goyang, Korea.

2. Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

3. Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Publisher

The Korean Society of Radiology

Subject

Radiology, Nuclear Medicine and imaging

Link

https://kjronline.org/pdf/10.3348/kjr.2022.0510

Reference20 articles.

1. 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

2. Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

3. Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma

4. Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

5. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arterial-Portal Venous Shunt after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma Patients: Risk factors and Impact on Patient Survival;Oncology;2024-02-26